Background--Few studies have investigated the longitudinal association between breastfeeding and maternal cardiovascular disease (CVD) outcomes. This study examined the association between breastfeeding and CVD hospitalization and mortality in a large Australian cohort.
C ardiovascular disease (CVD) is the leading cause of death for women worldwide. 1 Preventing CVD through modifying known lifestyle risk factors, such as being overweight and an unhealthy diet, is a key public health priority. Whereas changes in established lifestyle risk factors can lead to substantial reduction in risk of developing CVD, prevention approaches should also incorporate emerging knowledge about novel risk factors of CVD, including behaviors that are specific to women. There has been an urgent, global call to conduct more sex-specific research to better inform public health strategies. 2 Sex differences exist in the epidemiology, diagnosis, risk profile, and treatment of CVD. Compared with men, women generally develop CVD at a later age, present with different symptoms and risk factors, are underdiagnosed, and respond differently to various treatments. 2 Breastfeeding has emerged in recent years as a lifestyle risk factor that may be associated with CVD; however, the evidence is limited by the small number of observational studies, particularly longitudinal studies. 3 Prevalence of early initiation of breastfeeding within 1 hour of birth is 30% in high-income countries, 4 and around 79% of newborns in high-income countries are ever breastfed. 5 Globally, prevalence of exclusive breastfeeding for infants aged <6 months is 43%. 5 During pregnancy, profound metabolic changes occur in a mother's body to support fetal growth and prepare for lactation. 6 It has been hypothesized that breastfeeding, which increases metabolic expenditure by an estimated 480 kcal/day, may enable a more rapid reversal of metabolic changes in pregnancy, including improved insulin sensitivity, lipid metabolism, and greater mobilization of accumulated fat stores, thereby "resetting" maternal metabolism after pregnancy and potentially reducing maternal risk of cardiometabolic disease. 7 Multiple studies have reported the short-term benefits of breastfeeding, including lipid homeostasis, 8, 9 glucose homeostasis, and insulin sensitivity. 10, 11 However, whether these benefits can contribute to long-term maternal health is unclear.
Emerging evidence suggests that breastfeeding may reduce the risk of developing type 2 diabetes mellitus, 12 hypertension, 13 and metabolic syndrome 14 later in life.
Although a number of studies have examined the associations between breastfeeding and CVD outcomes, such as incidence of CVD 3, [15] [16] [17] [18] or death from CVD, 3, [19] [20] [21] [22] findings from these studies are inconclusive. An important issue to consider in interpreting these observational studies is confounding. 3 Mothers who have breastfed tend to be older, from a higher socioeconomic background, have achieved higher levels of education, and participate in health-promoting behaviors in comparison with non-breastfeeding mothers. 23, 24 Maternal characteristics, such as living in lower socioeconomic areas, have been strongly associated with not breastfeeding over subsequent births, 25 but residual confounding attributed to unmeasured factors may remain an issue. These socioeconomic factors and health-promoting behaviors may also potentially bias the association between breastfeeding and CVD outcomes, and although previous studies have adjusted for their confounding effects, [14] [15] [16] [17] 20, 21 they did not investigate potential effect modification by socioeconomic status and overall lifestyle. The aims of this article were to examine the association between breastfeeding and CVD hospitalization and mortality in a large cohort of middle-aged and older parous women. Findings from this study can help build the evidence base for breastfeeding as an additional strategy to prevent CVD.
Methods
The authors declare that all supporting data are available within the article (and its online supplementary files).
Study Population
The Sax Institute's 45 and Up Study is a large-scale, prospective cohort study of 123 815 men and 143 073 women aged ≥45 years residing in the state of New South Wales (NSW), Australia. From 2006 to 2009, potential participants were randomly sampled from the Department of Human Services enrollment database, the national health insurance provider, and were invited to take part in the study. Individuals joined the study by completing a postal questionnaire and providing informed consent for follow-up, which included linkage of questionnaire data to population health databases. The study methods have been described in detail elsewhere. 26 We included all women who completed a baseline questionnaire. Women who reported that they had ever been diagnosed with or recently treated for CVD (self-reported heart disease, stroke, or blood clot: n=21 797) or with a hospital admission in the 6 years preceding study entry (with a CVD diagnosis code in any diagnostic field or a CVD-related procedure code in any procedure code field 27 ; n=13 323)
were excluded from analysis. We further excluded those who were nulliparous (never given birth; n=15 654) or with unknown parity (n=918) at baseline and parous women with unknown breastfeeding duration (n=2187). The final study sample included 100 864 women with reported breastfeeding duration. A participant flow chart for this study is provided in Figure. The 45 and Up Study received ethics approval from the University of NSW Human Research Ethics Committee. Approval to use data from the 45 and Up Study for this article was obtained from the NSW Population and Health Services Ethics Committee.
Clinical Perspective
What Is New?
• Findings from this study add to the growing evidence base for the long-term benefits of breastfeeding for maternal cardiovascular health.
• Among parous women aged ≥45 years, ever breastfeeding and average breastfeeding duration per child up to 12 months were associated with substantially lower risk of developing and dying from cardiovascular disease.
• Findings were mostly consistent among women from different socioeconomic backgrounds and with different lifestyle risk.
What Are the Clinical Implications?
• This study provides evidence that breastfeeding is associated with long-term benefits for maternal cardiovascular health, in addition to its known benefits for infants and mothers.
• Breastfeeding may be promoted as an additional strategy by which parous women can reduce their risk of developing and dying from cardiovascular disease.
Measurement

Exposure
The baseline questionnaire for women (available at http:// www.saxinstitute.org.au/our-work/45-up-study/questionnaires/) included self-reported information on sociodemographic and lifestyle factors, height and body weight, and medical and reproductive history. Women were asked to report the number of children they had given birth to and also the cumulative amount of time spent breastfeeding across all pregnancies, based on the question: "For how many months, in total, have you breastfed?" The average breastfeeding duration per child was derived from answers to these questions and categorized as never breastfed, >0 to 6 (<6) months, >6 to 12 months, or >12 months. Breastfeeding was also explored as a binary variable in terms of whether a woman had ever versus never breastfed (also referred to as breastfeeding history).
Outcomes
Baseline questionnaire data were linked to hospital data from the admissions, such as dates of admission and discharge, and records all related diagnoses for each admission. These are coded using the World Health Organization International Classification of Diseases, Tenth Revision-Australian Modification (ICD-10-AM) system. The NSW Registrar of Births, Deaths, and Marriages captures all deaths in NSW with causes subsequently coded using the ICD-10-AM classification. In both data sources, the first CVD hospitalization or death since baseline was based on a primary diagnosis of CVD of either ischemic heart disease (ICD-10-AM codes: I20-I25) or cerebrovascular disease (ICD-10-AM codes: I61-I67, I69). 29, 30 Covariates rized as <150, 150-299, or ≥300 minutes per week), multivitamin use (for most of the last 4 weeks; yes/no), omega 3 or fish oil use (yes/no), use of aspirin (yes/no), and oral contraceptive use (ever/never). Reproductive history was based on number of children given birth to (1, 2, 3, or ≥4), mother's age for first child, and mother's age for last child. Medical history was assessed using family history of CVD (yes/no), family history of hypertension (yes/no), family history of diabetes mellitus (yes/no), self-reported hypertension/recent treatment for hypertension (yes/no), and selfreported diabetes mellitus/recent treatment for diabetes mellitus (yes/no).
Statistical Analysis
Baseline participant characteristics by breastfeeding history and duration are presented as means (SD) for continuous variables and as percentages for categorical variables. Differences in baseline characteristics were assessed using chisquare tests for categorical variables, Student t tests for continuous variables with binary breastfeeding categories, and F statistics from ANOVA for continuous variables with multiple lactation categories. Crude and adjusted hazard ratios (HRs) with 95% CIs were estimated for associations between either breastfeeding history or average breastfeeding duration per child and CVD outcomes by using Cox proportional hazards models. Separate models were used for CVD hospitalizations and CVD deaths with a time scale in years. In the analyses of incident CVD hospitalization, CVD death before hospitalization was not treated as a competing outcome; instead, participants were censored at death irrespective of cause of death. Eligible women contributed person-years from date of recruitment until admission date, date of death, or end of follow-up (June 18, 2014), whichever was the earliest; end of follow-up was December 31, 2013 for analyses of CVD mortality. Proportionality assumptions were verified based on the methods of Lin et al. 34 The "never breastfed" category was used as the reference category. Left-truncated data were used to adjust for different CVD risk exposure times for each woman before baseline entry into the study. 35 This approach helped to account for differences in the time that some women may have been diagnosed with CVD in the months or years preceding enrollment in the study. For each of the CVD outcomes, 4 sequential models were used: unadjusted models (model 1), models adjusted for parity and sociodemographic characteristics (number of children, age, country of birth, educational level, marital status, and area-level socioeconomic status; model 2), models further adjusted for lifestyle factors (body mass index, smoking status, alcohol intake, and physical activity; model 3), and models further adjusted for medical and reproductive covariates (multivitamin use, omega 3 or fish oil use, use of aspirin, oral contraceptive use, mother's age for first child, mother's age for last child, family history of CVD, family history of hypertension, family history of diabetes mellitus, self-reported hypertension/recent treatment for hypertension, and self-reported diabetes mellitus/recent treatment for diabetes mellitus; model 4). To account for potential interaction by socioeconomic status and lifestyle risk, multiplicative interaction terms were tested in the model, and analyses were stratified by educational attainment and a healthy lifestyle index, used as a marker for CVD lifestyle risk factors. The healthy lifestyle index has been adapted from a lifestyle risk index previously developed using the 45 and Up Study cohort 36 and the Healthy Heart Score developed by the Harvard School of Public Health. 37 It is based on the following 6 lifestyle risk factors scored individually as healthy (score=1) or not healthy (score=0): body mass index (<25 kg/m 2 =1, ≥25 kg/m 2 =0), physical activity level (<150 min/week=1; ≥150 min/week=0), smoking status (past/current smoker=0; never smoker=1), alcohol intake (≤14 drinks/week=1; >14 drinks/week=0), sleep (>7 to <9 h/day=1; <7 h/day or >9 h/day=0), and fruit and vegetable intake (<2 serves of fruit/day or <3 serves of fruit/day=0; ≥2 serves of fruit/day, and ≥3 serves of vegetables/day=1). For the stratified analyses, the healthy lifestyle index was dichotomized as either healthy (sum of scores=5-6) or not healthy (sum of scores=0-4). Interactions were considered significant if P<0.05. Statistical significance was defined as P<0.05 and analyses were conducted using SAS software (version 9.3; SAS Institute Inc., Cary, NC). Table 1 shows baseline sociodemographic characteristics and parity of the 100 864 parous women included in our study. Mean age of the sample was 60.2 (SD, 10.2) years. More than three-quarters (76.7%) of women were born in Australia, more than one-third (40%) had ≤10 years of education, threequarters (75.4%) were married, and nearly two-thirds (61.3%) belonged to the 3 lowest socioeconomic population-level quintiles. Of all parous women, 87.6% had a history of breastfeeding. On average, women had 2.7 (SD, 1.2) children and breastfed for 5.4 (SD, 5.4) months per child. Compared with women who never breastfed, women who ever breastfed were more likely to be younger at baseline, have more children, a higher level of education, be married/living with a partner, and live in an area with higher socioeconomic quintile. Women that had ever breastfed were also less likely to be obese, smoke, and were more likely to engage in higher levels of physical activity and consume omega 3 or fish oil. The 45 to 54 years age group was more likely to have a higher breastfeeding duration per child than the older age groups. Those who breastfed >12 months, on average, per child were more likely to have a university degree. The lifestyle, medical, and reproductive characteristics of women at baseline are presented in Table S1 . Table 2 shows HR and 95% CI for the incidence of CVD hospitalization and mortality by average breastfeeding duration per child. In both unadjusted and adjusted models, women who breastfed, on average, for >0 to 6 or >6 to 
Results
Participant Characteristics
Breastfeeding and CVD Hospitalization/Mortality
Stratified Analyses
Overall, none of the tests for interaction were statistically significant (all P>0.05). In the stratified analysis by education, the association between breastfeeding and CVD outcomes were similar across education strata (Table S3) , whereas, in the stratified analysis by healthy lifestyle index (Table S4) , the association between breastfeeding and CVD hospitalization was nonsignificant in those with lower lifestyle scores ("not healthy") while protective in those with higher lifestyle scores ("healthy"). However, the association with CVD mortality was similarly protective in those with low and high lifestyle scores.
Discussion
In this large cohort of parous women aged ≥45 years, ever breastfeeding and average breastfeeding duration up to 12 months per child were associated with lower risk of incident CVD hospitalization and CVD mortality. Following adjustment for sociodemographic, lifestyle-related, and reproductive variables, ever breastfeeding was associated with a 14% lower risk of CVD hospitalization and a 34% lower risk of mortality from CVD compared with never breastfeeding. Average breastfeeding duration per child up to 12 months was significantly associated with a 15% lower risk of incident CVD and a 40% lower risk of CVD mortality compared with never breastfeeding. Findings were mostly consistent among women from different socioeconomic backgrounds and with different lifestyle risk.
This longitudinal study provides further evidence that among childbearing women, breastfeeding may offer longterm cardiovascular health benefits. The protective nature of the association between breastfeeding history and CVD outcomes is generally consistent with findings from the few previous studies that have examined similar associations among parous women from large cohorts (Table S5) . 15, 16, 20 Differences between studies in magnitude of the associations could be attributed to variation in follow-up periods, types of CVD and outcomes examined, covariate adjustment, and cohort characteristics. Compared with previous studies, this study was novel in that it examined associations in an Australian setting, included more sociodemographic and lifestyle covariates, and stratified analyses by socioeconomic status and a healthy lifestyle index.
Whereas previous studies have typically expressed breastfeeding duration in terms of lifetime breastfeeding duration, we chose to present breastfeeding duration as the average duration per child to help standardize findings, better account for parity, and facilitate interpretation of findings. We modeled average breastfeeding duration as a categorical variable because of the nonlinearity of the distribution and chose clinically relevant cut points based on breastfeeding guidelines. This study showed that an average breastfeeding duration per child up to 12 months was associated with lower risk of incident CVD hospitalization and mortality compared with never breastfeeding. To our knowledge, there have been only 2 previous studies that have examined the association between average breastfeeding duration per child and CVD outcomes (Table S5) 15,16 and both have reported inverse associations. In the case-cohort study nested within EPIC (European Prospective Investigation into Cancer and Nutrition), an average breastfeeding duration ≥6 months, the highest breastfeeding duration considered, was associated with a 33% lower risk of incident ischemic heart disease. 15 In the China Kadoorie Biobank study, each additional 6 months of breastfeeding per child was associated with a 4% and 3% lower risk of incident ischemic heart disease and stroke, respectively. 16 However, different breastfeeding measures and study settings may limit the comparability of findings across studies. In the present study, there was no clear evidence for a doseresponse relationship between average lactation duration per child and CVD outcomes. In agreement with findings from our study, there was no solid evidence for a threshold or doseresponse effect in the few studies that have examined average breastfeeding duration per child. 15, 16 Whereas inconsistent associations have been shown between lifetime breastfeeding duration and CVD mortality, findings from some studies suggest a potential threshold effect 18 or a U-shaped association. 21 However, further longitudinal research is needed.
Strengths and Limitations
Strengths of this study include a large cohort size and prospective follow-up, which enabled us to examine the association between breastfeeding and long-term cardiovascular outcomes. Compared with previous studies, this study adjusted for a comprehensive range of covariates including relevant sociodemographic, lifestyle and reproductive factors, and sensitivity analyses stratified by socioeconomic status and a healthy lifestyle index were conducted. Several limitations should be mentioned. As for all observational studies, residual confounding may be an issue. Mothers that have breastfed may generally lead healthier lifestyles and come from higher socioeconomic backgrounds 23, 24 that could have contributed to the observed associations. However, adjusting for socioeconomic factors and lifestyle-related covariates did not alter the findings of this study, and associations appeared mostly consistent across different education and lifestyle categories. Some of the findings should nonetheless be interpreted with caution because of small cell-sample sizes in some of the stratified analyses, and particularly in relation to CVD mortality. Our results may also be subject to reverse causation. From the data collected, we could not assess whether women had preexisting metabolic conditions, such as obesity and type 1 diabetes mellitus, or conditions during pregnancy, such as pre-eclampsia and gestational diabetes mellitus, which could have unfavorably influenced breastfeeding practice. [38] [39] [40] Breastfeeding duration was assessed retrospectively many years later and may be prone to recall bias, which can lead to under-or over-reporting of breastfeeding duration. 41 However, maternal recall of lactation has been shown to be a valid and reliable measure, 41 even many years following weaning. 42 Finally, it was also not possible to assess the exclusivity of breastfeeding (ie, whether other complementary foods were being offered to breastfed children), which is a measure of breastfeeding intensity.
Implications and Conclusions
With CVD being the leading cause of death in women, it is important to explore a range of strategies by which CVD can be prevented, involving established as well as emerging lifestyle behaviors. This study provides evidence that ever breastfeeding and average breastfeeding duration up to 12 months per child were associated with substantially lower risk of CVD hospitalization and mortality. Although further longitudinal studies are needed to achieve greater consensus, findings from this study add to the growing evidence base for the long-term benefits of breastfeeding for maternal cardiovascular health, promoting added benefits of breastfeeding beyond known benefits for infants and short-term benefits for mothers, and support breastfeeding as an important strategy by which parous women can reduce their risk of developing and dying from CVD. (past/current smoker=score 0; never smoker=score 1), alcohol intake (≤14 drinks/week=score 0; >14 drinks/week=score 1), sleep (>7-<9 hours/day=score 0; <7 hours/day or >9 hours/day=score 1), fruit and vegetable intake (<2 serves of fruit/day and <3 serves of fruit/day=score 0; ≥2 serves of fruit/day and ≥3 serves of vegetables/day=score 1). Based on the sum of these scores, the healthy lifestyle index was dichotomised as either healthy (sum of scores=5-6) or not healthy (sum of scores=0-4). † Average breastfeeding duration per child was calculated as self-reported lifetime breastfeeding duration divided by the reported number of children. ‡ Adjusted for age, country of birth, educational level, marital status, area-level socio-economic status, multi-vitamin use, omega 3 or fish oil use, use of aspirin, oral contraceptive use, number of children, mother's age for first child, mother's age for last child, family history of CVD, family history of hypertension, family history of diabetes, self-reported hypertension/recent treatment for hypertension, and self-reported diabetes/recent treatment for diabetes. * Among parous women that had ever breastfed.
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